Clinical Trials Browser

Phase 2 × NETWORK × Uterine Cervical Neoplasms × Clear all

NCT01590017 2022-07-27

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Phase 2 Completed

41 enrolled 10 charts

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, HIV Infections

NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Phase 2 Withdrawn

Uterine Cervical Neoplasms, HIV Infections

NCT01266460 2020-09-11

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

54 enrolled 12 charts

Uterine Cervical Neoplasms

NCT01267253 2019-03-20

Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

31 enrolled 9 charts

Uterine Cervical Neoplasms

NCT00331760 2019-02-26

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery

Phase 2 Completed

106 enrolled 14 charts

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT00087126 2019-01-08

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

27 enrolled 6 charts

Uterine Cervical Neoplasms

NCT00309959 2019-01-08

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

37 enrolled 7 charts

Uterine Cervical Neoplasms

NCT00041093 2018-01-10

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00691301 2018-01-09

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 2 Completed

55 enrolled 10 charts

Uterine Cervical Neoplasms

NCT00081263 2017-09-15

Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia

Phase 2 Completed

130 enrolled 9 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00039442 2017-08-24

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT02501278 2016-05-13

A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT00217633 2015-05-29

Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00499031 2015-01-13

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

38 enrolled 9 charts

Uterine Cervical Neoplasms

NCT00101192 2014-03-17

Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 2 Completed

76 enrolled 8 charts

Uterine Cervical Neoplasms

NCT00087113 2014-02-14

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00002478 2013-06-10

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT00002813 2013-05-27

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00016926 2013-05-27

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00276796 2013-05-27

Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00003624 2013-04-11

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Phase 2 Terminated

GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Neurotoxicity Syndromes

NCT00006224 2013-04-11

Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT00006482 2013-04-11

Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT00030472 2013-04-11

Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT00002916 2012-07-02

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00003369 2012-06-14

S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms